Open Access Journal

Journal of AIDS and HIV Infections

ISSN: 2454-499X IF: 3.1* DOI: 10.15744

Email: jahi@annexpublishers.com

Submit Manuscript → Browse Articles Instructions for Authors

Journal at a Glance

Review typeDouble-blind

Target decision~21 days

Submission feeNone

LicenceCC BY 4.0

Word limitsNone

About

About the Journal

Journal of AIDS and HIV Infections (JAHI) provides a global open access platform for the researchers and academicians to put forth the research and relevant discussions on the current issues related to HIV and AIDS. JAHI accepts articles in all areas of AIDS and HIV which covers Epidemiology of HIV, HIV prevention, Vaccine Development, Pathogenicity of HIV/AIDS, etc.

Why publish with us

Built for researchers

⚡

Fast peer review

Target first decision within 21 days. Double-blind review by 2-3 field experts.

🔓

Fully open access

All articles CC BY 4.0. No paywalls. Compliant with funder mandates worldwide.

🔗

DOI & indexing

Every article receives a unique DOI. Indexed in PubMed, Google Scholar, CrossRef.

🚀

Rapid publication

Published within 7 days of acceptance. No unnecessary delays in dissemination.

🌐

Global & equitable

Readers in 170+ countries. Waiver program available for authors from developing nations.

📈

No content limits

No word limits. Multiple article formats: research, reviews, case reports, short communications.

How it works

Simple. Transparent. Streamlined.

Submit

Upload your manuscript via our online portal. Quality check within 48 hours.

Review

Double-blind peer review by 2-3 field experts. Target decision: ~21 days.

Revise

Constructive feedback from reviewers. Dedicated editorial support throughout.

Publish

Published within 7 days. DOI assigned via CrossRef. Globally indexed.

Submit Manuscript →

Highlights

Research Highlights

Nondaily preexposure prophylaxis for HIV prevention

To discuss nondaily preexposure prophylaxis (PrEP) modalities that may provide advantages compared with daily PrEP in cost and cumulative toxicity, but may have lower adherence forgiveness.

Neurologic Complications of Human Immunodeficiency Virus Infection

Neurologic complications of human immunodeficiency virus (HIV) infection remain common, despite effective antiretroviral treatment (ART).

Sustainable HIV treatment in Africa through viral-load-informed differentiated care

There are inefficiencies in current approaches to monitoring patients on antiretroviral therapy in sub-Saharan Africa. Patients typically attend clinics every 1 to 3 months for clinical assessment.

Determinants of late presentation to HIV/AIDS care in Southern Tigray Zone, Northern Ethiopia: an institution based case-control study

Late diagnosis and presentation to human immune deficiency virus (HIV)/acquired immune deficiency syndrome care reduce the benefits of antiretroviral therapy and increase the risk of HIV transmission.